Logo image
Back
The Australian and New Zealand Society for Sarcopenia and Frailty Research (ANZSSFR) sarcopenia diagnosis and management task force: Findings from the consumer expert Delphi process
Journal article   Open access   Peer reviewed

The Australian and New Zealand Society for Sarcopenia and Frailty Research (ANZSSFR) sarcopenia diagnosis and management task force: Findings from the consumer expert Delphi process

Jesse Zanker, Marc Sim, Kate Anderson, Saliu Balogun, Sharon L Brennan-Olsen, Elsa Dent, Gustavo Duque, Christian M Girgis, Mathis Grossmann, Alan Hayes, …
Australasian Journal on Ageing, Vol.42(1), pp.251-257
2023
DOI: https://doi.org/10.1111/ajag.13164
PMCID: PMC10947359
PMID: 36480154
Appears in  UniSC Diversity and Inclusion Research Collection
pdf
Australas J Ageing - 2022 - Zanker - The Australian and New Zealand Society for Sarcopenia and Frailty Research ANZSSFR 573.81 kBDownloadView
Published Version Open Access CC BY V4.0
url
https://doi.org/10.1111/ajag.13164View
Published Version

Abstract

geriatric assessment community-based participatory research sarcopenia UniSC Diversity Area - Life Stages
Objectives: To develop guidelines, informed by health-care consumer values and preferences, for sarcopenia prevention, assessment and management for use by clinicians and researchers in Australia and New Zealand. Methods: A three-phase Consumer Expert Delphi process was undertaken between July 2020 and August 2021. Consumer experts included adults with lived experience of sarcopenia or health-care utilisation. Phase 1 involved a structured meeting of the Australian and New Zealand Society for Sarcopenia and Frailty Research (ANZSSFR) Sarcopenia Diagnosis and Management Task Force and consumer representatives from which the Phase 2 survey was developed. In Phase 2, consumers from Australia and New Zealand were surveyed online with opinions sought on sarcopenia outcome priorities, consultation preferences and interventions. Findings were confirmed and disseminated in Phase 3. Descriptive statistical analyses were performed. Results: Twenty-four consumers (mean ± standard deviation age 67.5 ± 12.8 years, 18 women) participated in Phase 2. Ten (42%) identified as being interested in sarcopenia, 7 (29%) were health-care consumers and 6 (25%) self-reported having/believing they have sarcopenia. Consumers identified physical performance, living circumstances, morale, quality of life and social connectedness as the most important outcomes related to sarcopenia. Consumers either had no preference (46%) or preferred their doctor (40%) to diagnose sarcopenia and preferred to undergo assessments at least yearly (54%). For prevention and treatment, 46% of consumers preferred resistance exercise, 2–3 times per week (54%). Conclusions: Consumer preferences reported in this study can inform the implementation of sarcopenia guidelines into clinical practice at local, state and national levels across Australia and New Zealand.

Details

Metrics

105 File views/ downloads
140 Record Views
12 Times Cited - Web of Science

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Web Of Science research areas
Geriatrics & Gerontology
Gerontology

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#2 Zero Hunger
#3 Good Health and Well-Being
#5 Gender Equality

Source: SDGs from InCites

Logo image